Years of research, clinical, operational and investment success give the RiverVest® team an edge in identifying life science innovations that present the greatest potential for commercialization.

Together, we work diligently and consistently to apply our deep domain expertise and strong industry relationships to help entrepreneurs drive their companies forward.

Jay W. Schmelter Managing Director	Thomas C. Melzer Managing Director	John McKearn, Ph.D. Managing Director	Karen Spilizewski Vice President	Niall O’Donnell, Ph.D. Principal
Andrew B. Craig III Retired Special Limited Partner	Marilyn J. Slavich Controller	Kelly K. Cathey Office Managerr	Corrin J. Short Executive Assistant

Scientific & Industry Advisory Board

Michael Berman	Floyd E. Bloom, M.D.	Joseph M. Davie, M.D., Ph.D.	Nancy J. Hutson, Ph.D.	William A. Peck, M.D.